The Use of Levosimendan for the Treatment of Heart Failure and its Potential Organoprotective Effects
| Autor: | N. B. Lebedeva, L. Yu. Chesnokova |
|---|---|
| Jazyk: | English<br />Russian |
| Rok vydání: | 2022 |
| Předmět: | |
| Zdroj: | Рациональная фармакотерапия в кардиологии, Vol 18, Iss 2, Pp 218-224 (2022) |
| Druh dokumentu: | article |
| ISSN: | 1819-6446 2225-3653 |
| DOI: | 10.20996/1819-6446-2022-04-12 |
| Popis: | The review article is aimed at providing a recent update on the use of levosimendan, an inotropic drug in current use for the treatment of heart failure. The review discusses its mechanisms of action, main hemodynamic effects, clinical trials and obtained evidences that have formed the basis of the current guidelines on its use, as well as the latest clinical and experimental trials evaluating its organ-protective effects. Conclusion: levosimendan has a promising potential for treating heart failure, prescribed even in low doses, and may be regarded as a drug with cerebroprotective and possible nephroprotective effects, requiring further large randomized clinical trials. |
| Databáze: | Directory of Open Access Journals |
| Externí odkaz: |
|